Bio & Health Innovation in China: R&D Focus Areas, Ecosystem Landscape, and Future Careers

Darren is a founder and managing partner of Sherpa Healthcare Partners, investing in the health and biotech sector. He previously held senior roles in Legend Capital and Beijing Genomics Institute. Darren holds a PhD degree from UC Berkeley, an MBA degree from Yale, and a BS degree from the University of Science and Technology of China.

Kevin is the CEO of Salubris Pharmaceuticals, a China-based pharma leader. Kevin took the company public in 2009 in China’s Shenzhen Stock Exchange. Kevin is a member of Yale Asia Development Council, Yale SOM Greater China Advisory Board, and president of the Yale Club of Shenzhen. He received his BBA from the University of Michigan and MBA from Yale.

Shawn is currently head of Greater China & the Emerging Asia Region for Abbott Diabetes Care. He previously held various management roles at Novartis China and served as global pharma strategy director at Novartis in Switzerland. He began his career with McKinsey focused on the biotech and biopharma industry. Shawn holds a PhD from Yale and a BS from Peking University.

Xiaoyan is a cardiologist and medical director of general cardiology at Providence Heart Institute in Portland, Oregon. She is the immediate-past president of medical staff at Providence Milwaukie Hospital. Xiaoyan holds an MD from Stanford Medical, an MS in public health from Harvard, and a BS from Yale. She is the new vice chair of the Yale Alumni Association Board of Governors.